Understanding review, deprescribing conversations and safer alternatives when antipsychotics have become routine in dementia care.
This article provides general education for care providers. It does not replace assessment by the resident’s GP, community services, safeguarding team, mental capacity decision-maker, prescriber or emergency services where required. Resident-identifiable information should not be shared through website enquiries.
Reduction is not simply “stop the tablet”
Antipsychotic reduction should be planned and led by the appropriate prescriber or clinical team. The care home’s role is to support accurate information, consistent care planning, monitoring and timely escalation if distress or risk returns.
Why antipsychotics continue longer than intended
- The original crisis was never formally reviewed
- The target symptom was not clearly documented
- Staff fear behaviour will return if medication changes
- The care plan did not change after prescribing
- Reviews focus on repeat prescription rather than current need
Before reduction is considered
- What was the original indication?
- What behaviour or distress is currently present?
- What has changed in health, staffing, environment or routine?
- Are non-drug strategies in place and used consistently?
- What would count as deterioration and who would review it?
Good signs reduction may be possible
- No recent target symptoms
- Stable presentation over time
- Clear triggers now understood and managed
- Improved environment or staffing consistency
- Medication burden, sedation, falls, swallowing problems or other side effects are a concern
Reduction needs monitoring
Care teams need to know what to record, how often to review, and when to escalate. Families may also need clear communication so reduction is not misread as withdrawal of care.
Mini case example
A resident had been prescribed an antipsychotic during a period of severe aggression linked to a move into care. Six months later, incidents had reduced, staff knew the triggers and a consistent personal care plan was in place. The home provided the prescriber with clear behaviour records, current risks and staff observations to support a planned review conversation.
Sources and UK guidance basis
- NICE NG97, including review of antipsychotic treatment and discussion of benefits and harms.
- CQC guidance on appropriate use of psychotropic medicines in adult social care.
- Local NHS prescribing guidance may set more detailed review, monitoring and tapering arrangements.
What this article cannot do
General articles can help teams think more clearly, but repeated incidents, safeguarding concerns, placement instability, complex family dynamics, prescribing questions or restrictive practice need case-specific review by the appropriate accountable professionals.
First Response Dementia Services provides focused dementia behaviour review, formulation and practical care planning support for care providers. The aim is to help teams understand the pattern, strengthen documentation and agree realistic next steps.